Cahill Represented Debt Financing Sources in $635 Million of Debt Financings, Consisting of $565 Million First Lien Credit Facilities and $70 Million in Asset-Based Revolving Credit Facility for Pelican Products, Inc. and Peacock Bio Holding, L.P.
Date: 12/31/21
Cahill represented the lead arrangers in connection with a $40,000,000 cash flow revolving credit facility, a $525,000,000 first lien cash flow term B credit facility and a $70,000,000 asset-based revolving credit facility for Pelican Products, Inc. and Peacock Bio Holding, L.P. Proceeds from the credit facilities will be used for the acquisition of Pelican Products by Platinum Equity Advisers and for general corporate purposes. Pelican is a global leader in the design and manufacture of high-performance protective cases and rugged gear for professionals and outdoor enthusiasts, and temperature-controlled supply chain solutions for the healthcare industry.